Ningbo David Medical Device Co., Ltd. (SHE:300314)
9.66
+0.35 (3.76%)
Jul 1, 2026, 3:04 PM CST
SHE:300314 Revenue
Ningbo David Medical Device had revenue of 112.80M CNY in the quarter ending March 31, 2026, a decrease of -6.90%. This brings the company's revenue in the last twelve months to 575.66M, up 16.80% year-over-year. In the year 2025, Ningbo David Medical Device had annual revenue of 584.03M with 10.82% growth.
Revenue (ttm)
575.66M
Revenue Growth
+16.80%
P/S Ratio
4.83
Revenue / Employee
625.72K
Employees
920
Market Cap
2.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 584.03M | 57.00M | 10.82% |
| Dec 31, 2024 | 527.03M | -91.27M | -14.76% |
| Dec 31, 2023 | 618.30M | 112.26M | 22.18% |
| Jan 1, 2023 | 506.04M | 31.90M | 6.73% |
| Jan 1, 2022 | 474.13M | 14.60M | 3.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Canopus Wisdom Medical Technology | 3.94B |
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.65B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Guangdong Transtek Medical Electronics | 996.64M |
| Chison Medical Technologies | 435.38M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 342.66M |
| Kontour (Xi'an) Medical Technology | 342.27M |
| Beijing Leadman Biochemistry | 317.86M |